| Mesoporous silica nanoparticle-supported lipid bilayers (protocells) for active targeting and delivery to individual leukemia cells PN Durfee, YS Lin, DR Dunphy, AJ Muñiz, KS Butler, KR Humphrey, ... ACS nano 10 (9), 8325-8345, 2016 | 221 | 2016 |
| Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities JO Agola, PA Jim, HH Ward, S Basuray, A Wandinger‐Ness Clinical genetics 80 (4), 305-318, 2011 | 163 | 2011 |
| Antibacterial countermeasures via metal–organic framework-supported sustained therapeutic release DF Sava Gallis, KS Butler, JO Agola, CJ Pearce, AA McBride ACS applied materials & interfaces 11 (8), 7782-7791, 2019 | 122 | 2019 |
| Re-examining the size/charge paradigm: differing in vivo characteristics of size-and charge-matched mesoporous silica nanoparticles JL Townson, YS Lin, JO Agola, EC Carnes, HS Leong, JD Lewis, ... Journal of the American Chemical Society 135 (43), 16030-16033, 2013 | 112 | 2013 |
| A Competitive Nucleotide Binding Inhibitor: In Vitro Characterization of Rab7 GTPase Inhibition JO Agola, L Hong, Z Surviladze, O Ursu, A Waller, JJ Strouse, ... ACS chemical biology 7 (6), 1095-1108, 2012 | 109 | 2012 |
| NMR Characterization of Phosphonic Acid Capped SnO2 Nanoparticles GP Holland, R Sharma, JO Agola, S Amin, VC Solomon, P Singh, ... Chemistry of Materials 19 (10), 2519-2526, 2007 | 106 | 2007 |
| Versatile surface functionalization of metal–organic frameworks through direct metal coordination with a phenolic lipid enables diverse applications W Zhu, G Xiang, J Shang, J Guo, B Motevalli, P Durfee, JO Agola, ... Advanced Functional Materials 28 (16), 1705274, 2018 | 105 | 2018 |
| SupraCells: living mammalian cells protected within functional modular nanoparticle‐based exoskeletons W Zhu, J Guo, S Amini, Y Ju, JO Agola, A Zimpel, J Shang, A Noureddine, ... Advanced Materials 31 (25), 1900545, 2019 | 99 | 2019 |
| Metal–organic framework nanoparticle-assisted cryopreservation of red blood cells W Zhu, J Guo, JO Agola, JG Croissant, Z Wang, J Shang, E Coker, ... Journal of the American Chemical Society 141 (19), 7789-7796, 2019 | 85 | 2019 |
| Biomimetic rebuilding of multifunctional red blood cells: modular design using functional components J Guo, JO Agola, R Serda, S Franco, Q Lei, L Wang, J Minster, ... Acs Nano 14 (7), 7847-7859, 2020 | 73 | 2020 |
| Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery A Noureddine, A Maestas-Olguin, EA Saada, AE LaBauve, JO Agola, ... Acta Biomaterialia 114, 358-368, 2020 | 67 | 2020 |
| Multifunctional protocells for enhanced penetration in 3D extracellular tumoral matrices MR Villegas, A Baeza, A Noureddine, PN Durfee, KS Butler, JO Agola, ... Chemistry of Materials 30 (1), 112-120, 2018 | 62 | 2018 |
| Modular Metal–Organic Polyhedra Superassembly: From Molecular‐Level Design to Targeted Drug Delivery W Zhu, J Guo, Y Ju, RE Serda, JG Croissant, J Shang, E Coker, JO Agola, ... Advanced Materials 31 (12), 1806774, 2019 | 60 | 2019 |
| Novel activities of select NSAID R-enantiomers against Rac1 and Cdc42 GTPases TI Oprea, LA Sklar, JO Agola, Y Guo, M Silberberg, J Roxby, A Vestling, ... PLoS One 10 (11), e0142182, 2015 | 47 | 2015 |
| A Pan-GTPase inhibitor as a molecular probe L Hong, Y Guo, S BasuRay, JO Agola, E Romero, DS Simpson, ... PLoS One 10 (8), e0134317, 2015 | 40 | 2015 |
| Modular assembly of red blood cell superstructures from metal–organic framework nanoparticle‐based building blocks J Guo, Y Yu, W Zhu, RE Serda, S Franco, L Wang, Q Lei, JO Agola, ... Advanced Functional Materials 31 (10), 2005935, 2021 | 32 | 2021 |
| Rapid parallel flow cytometry assays of active GTPases using effector beads T Buranda, S BasuRay, S Swanson, J Agola, V Bondu, ... Analytical biochemistry 442 (2), 149-157, 2013 | 28 | 2013 |
| A small molecule pan-inhibitor of Ras-superfamily GTPases with high efficacy towards Rab7 L Hong, P Simons, A Waller, J Strouse, Z Surviladze, O Ursu, C Bologa, ... Probe Reports from the NIH Molecular Libraries Program [Internet], 2013 | 17 | 2013 |
| Carriers for Plasmid and RNP Delivery in the Treatment of Cancer and Other Disease States CJ Brinker, EC Carnes, CE Ashley, J Santarpia, AC Greene, O Negrete, ... US Patent App. 15/474,810, 2018 | 16 | 2018 |
| Robust and long-term cellular protein and enzymatic activity preservation in biomineralized mammalian cells J Guo, S Amini, Q Lei, Y Ping, JO Agola, L Wang, L Zhou, J Cao, S Franco, ... ACS nano 16 (2), 2164-2175, 2022 | 15 | 2022 |
